Cargando…
Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol
INTRODUCTION: Cancer is a major health problem worldwide and the leading cause of death in many countries. The number of patients with cancer and socioeconomic costs of cancer continues to increase. SH003 is a novel herbal medicine consisting of Astragalus membranaceus, Angelica gigas and Trichosant...
Autores principales: | Cheon, Chunhoo, Kang, Sohyeon, Ko, Youme, Kim, Mia, Jang, Bo-Hyoung, Shin, Yong-Cheol, Ko, Seong-Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078237/ https://www.ncbi.nlm.nih.gov/pubmed/30082340 http://dx.doi.org/10.1136/bmjopen-2017-019502 |
Ejemplares similares
-
Sipjeondaebo-tang in patients with breast cancer with fatigue: a protocol for a pilot, randomised, double-blind, placebo-controlled, cross-over trial
por: Cheon, Chunhoo, et al.
Publicado: (2018) -
A Phase I Study to Evaluate the Safety of the Herbal Medicine SH003
in Patients With Solid Cancer
por: Cheon, Chunhoo, et al.
Publicado: (2020) -
Sipjeondaebo-tang in patients with cancer with anorexia: a protocol for a pilot, randomised, controlled trial
por: Cheon, Chunhoo, et al.
Publicado: (2016) -
Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol
por: Cheon, Chunhoo, et al.
Publicado: (2020) -
Maekmoondong-tang in treatment of postoperative cough in patients with lung cancer: Study protocol for a randomized, double-blind, placebo-controlled, multicenter trial
por: Cheon, Chunhoo, et al.
Publicado: (2018)